Sin financiación14.299 JCR (2018) Q1, 2/31 Rheumatology7.081 SJR (2018) Q1, 6/263 Biochemistry, Genetics and Molecular Biology (miscellaneous)No data IDR 2018UE
Inflammatory uveitis is a difficult condition to treat. Recently, a new class of drugs obtained by a...
cited By 1International audienceIntroduction: Conventional immunosuppressive drugs, anti-TNF alpha t...
Systemic immunomodulatory therapies are the principal means of managing non-infectious uveitis. This...
Background: Non-infectious non-anterior uveitis (NINA) is a sight-threatening condition that often r...
Clinical trials in uveitis have led to the expansion of therapeutic options for the management of no...
Uveitis, a group of conditions characterized by intraocular inflammation, is a major cause of sight ...
An international, expert-led consensus initiative to develop systematic, evidence-based recommendati...
Background Acute anterior uveitis (AAU) is the most common form of uveitis. Most of them are idiopat...
Uveitis is one of the most common causes of vision loss and blindness worldwide. Local and/or system...
Topic: An international, expert-led consensus initiative to develop systematic, evidence-based recom...
Topic: An international, expert-led consensus initiative to develop systematic, evidence-based recom...
: To conduct a systematic review of effectiveness of pharmacological therapies for treatment of Uvei...
Topic: An international, expert-led consensus initiative to develop systematic, evidence-based recom...
Introduction: Noninfectious uveitis represents one of the leading causes of blindness in developed C...
Objetivo Desarrollar recomendaciones basadas en la mejor evidencia disponible y experiencia sobre el...
Inflammatory uveitis is a difficult condition to treat. Recently, a new class of drugs obtained by a...
cited By 1International audienceIntroduction: Conventional immunosuppressive drugs, anti-TNF alpha t...
Systemic immunomodulatory therapies are the principal means of managing non-infectious uveitis. This...
Background: Non-infectious non-anterior uveitis (NINA) is a sight-threatening condition that often r...
Clinical trials in uveitis have led to the expansion of therapeutic options for the management of no...
Uveitis, a group of conditions characterized by intraocular inflammation, is a major cause of sight ...
An international, expert-led consensus initiative to develop systematic, evidence-based recommendati...
Background Acute anterior uveitis (AAU) is the most common form of uveitis. Most of them are idiopat...
Uveitis is one of the most common causes of vision loss and blindness worldwide. Local and/or system...
Topic: An international, expert-led consensus initiative to develop systematic, evidence-based recom...
Topic: An international, expert-led consensus initiative to develop systematic, evidence-based recom...
: To conduct a systematic review of effectiveness of pharmacological therapies for treatment of Uvei...
Topic: An international, expert-led consensus initiative to develop systematic, evidence-based recom...
Introduction: Noninfectious uveitis represents one of the leading causes of blindness in developed C...
Objetivo Desarrollar recomendaciones basadas en la mejor evidencia disponible y experiencia sobre el...
Inflammatory uveitis is a difficult condition to treat. Recently, a new class of drugs obtained by a...
cited By 1International audienceIntroduction: Conventional immunosuppressive drugs, anti-TNF alpha t...
Systemic immunomodulatory therapies are the principal means of managing non-infectious uveitis. This...